Empresa Karolinska Development AB
Acciones
KDEV
SE0002190926
Equipo médico, suministros y distribución
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,548 SEK | +1,57 % | +2,11 % | -8,83 % |
Resumen de negocios
Número de empleados: 8
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -12,43 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director of Finance/CFO | 56 | 01/10/22 | |
John Öhd
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/06/20 |
Chief Investment Officer | 58 | 01/03/21 | |
Linda Spahiu
PRN | Corporate Officer/Principal | 39 | - |
Johan Dighed
LAW | General Counsel | 51 | 01/05/20 |
Corporate Officer/Principal | 59 | 01/11/15 | |
Eva Montgomerie
AUD | Comptroller/Controller/Auditor | 66 | 01/01/07 |
Thomas Andersson
PRN | Corporate Officer/Principal | 72 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Björn Cochlovius
CHM | Chairman | 56 | 01/01/20 |
Viktor Drvota
CEO | Chief Executive Officer | 59 | 07/12/15 |
Director/Board Member | 55 | 19/02/21 | |
Benjamin Toogood
BRD | Director/Board Member | 48 | 19/02/21 |
Theresa Tse
BRD | Director/Board Member | 32 | 28/11/17 |
Philip Duong
BRD | Director/Board Member | 34 | 12/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 10 | 2 555 261 | 0 | 0 | 35,96 % |
Acción B | 1 | 267 522 333 | 97 108 178 ( 36,30 %) | 0 |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
OSSDSIGN AB 9.83% | 9 596 662 | 9.83% | 8 235 663 $ |
Información de la empresa
Karolinska Development AB
Tomtebodavägen 23 A
171 65, Solna
+46 8 52 48 60 70
http://www.karolinskadevelopment.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. |
Biotechnology
|
Sector
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-8,83 % | 38,72 M | |
+3,26 % | 197 mil M | |
+5,79 % | 115 mil M | |
+1,48 % | 71,22 mil M | |
+11,77 % | 53,77 mil M | |
+18,31 % | 48,75 mil M | |
+6,87 % | 44,22 mil M | |
+12,38 % | 28,85 mil M | |
+9,76 % | 28,57 mil M | |
+10,35 % | 27,62 mil M |
- Bolsa
- Acciones
- Acción Karolinska Development AB - Nasdaq Stockholm
- Empresa Karolinska Development AB